Literature DB >> 12509631

Younger age of onset of gout in Taiwan.

K-H Yu1, S-F Luo.   

Abstract

OBJECTIVE: To study the clinical features of gout in the community and in medical centres, and to describe the recent changes in gout in Chinese patients.
METHODS: We analysed retrospectively the clinical features of 1079 Chinese gout patients seen by a rheumatologist between 1993 and 2000. These included 558 patients from a private clinic and 521 patients from a medical centre. The data were compared with those in previous reports of large Caucasian and non-Caucasian series.
RESULTS: The mean age of onset was 41.6 yr and the mean disease duration before first visit was 4.2 yr. For medical centre patients, the mean age of onset was 43.0 yr and mean disease duration before the first visit was 4.8 yr. For private clinic patients, the mean age of onset was 40.2 yr and mean disease duration before the first visit was 3.6 yr. Young patients with gout, with onset before age 30, constituted 23.3 and 26.7% of the medical centre and private clinic patients respectively. Female patients constituted 10.6 and 5.6% respectively, the family history was positive in 27.1 and 28.7%, and urolithiasis occurred in 11.5 and 10.9%. Tophi were found in 21.1% of medical centre and 12.7% of private clinic patients. The mean time from first gouty attack to visible tophi was 6.6 yr in those who developed tophi.
CONCLUSIONS: The age at onset of gout was much earlier than in previous reports. Twenty-five per cent of patients had their first gouty attack before age 30. The first attack frequently occurred between the third and fifth decades (68.2%) rather than between the fourth and sixth decades, as reported in previous papers. The incidence of gout in females had increased (8.0% of the patients were female) and the incidence of tophi was high (16.8%). Besides, our patients had more frequent gouty attacks and the interval from the first attack to visible tophi was shorter than in previous reports of the disease in Caucasians.

Entities:  

Mesh:

Year:  2003        PMID: 12509631     DOI: 10.1093/rheumatology/keg035

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  15 in total

1.  Obesity and younger age at gout onset in a community-based cohort.

Authors:  Mara A McAdams DeMarco; Janet W Maynard; Mary Margret Huizinga; Alan N Baer; Anna Köttgen; Allan C Gelber; Josef Coresh
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-08       Impact factor: 4.794

2.  Epidemiology of urolithiasis: an update.

Authors:  Alberto Trinchieri
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

3.  Coexisting ankylosing spondylitis and gouty arthritis.

Authors:  Huei-Huang Ho; Kuang-Hui Yu; Ji-Yih Chen; Ja-Liang Lin; Yeong-Jian Jan Wu; Shue-Fen Luo; Lieh-Bang Liou
Journal:  Clin Rheumatol       Date:  2007-03-14       Impact factor: 2.980

Review 4.  New developments in the epidemiology and genetics of gout.

Authors:  Raihana Zaka; Charlene J Williams
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.686

5.  New urea and thiourea derivatives of piperazine doped with febuxostat: synthesis and evaluation of anti-TMV and antimicrobial activities.

Authors:  Reddivari Chenna Krishna Reddy; Syed Rasheed; Devineni Subba Rao; Shaik Adam; Yellala Venkata Rami Reddy; Chamarthi Naga Raju
Journal:  ScientificWorldJournal       Date:  2013-12-26

6.  Epidemiology and management of gout in Taiwan: a nationwide population study.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Lai-Chu See; Kuang-Hui Yu; Shue-Fen Luo; Weiya Zhang; Michael Doherty
Journal:  Arthritis Res Ther       Date:  2015-01-23       Impact factor: 5.156

7.  Clinical characteristics of early- and late-onset gout: A cross-sectional observational study from a Chinese gout clinic.

Authors:  Bingqing Zhang; Weigang Fang; Xuejun Zeng; Yun Zhang; Ya Ma; Feng Sheng; Xinlei Zhang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

8.  Monosodium urate crystal deposition associated with the progress of radiographic grade at the sacroiliac joint in axial SpA: a dual-energy CT study.

Authors:  Junqing Zhu; Aiwu Li; Ertao Jia; Yi Zhou; Juan Xu; Shixian Chen; Yinger Huang; Xiang Xiao; Juan Li
Journal:  Arthritis Res Ther       Date:  2017-05-02       Impact factor: 5.156

9.  Urate-lowering treatment and risk of total joint replacement in patients with gout.

Authors:  Chang-Fu Kuo; I-Jun Chou; Lai-Chu See; Jung-Sheng Chen; Kuang-Hui Yu; Shue-Fen Luo; Ao-Ho Hsieh; Weiya Zhang; Michael Doherty
Journal:  Rheumatology (Oxford)       Date:  2018-12-01       Impact factor: 7.580

10.  Common dysfunctional variants in ABCG2 are a major cause of early-onset gout.

Authors:  Hirotaka Matsuo; Kimiyoshi Ichida; Tappei Takada; Akiyoshi Nakayama; Hiroshi Nakashima; Takahiro Nakamura; Yusuke Kawamura; Yuzo Takada; Ken Yamamoto; Hiroki Inoue; Yuji Oikawa; Mariko Naito; Asahi Hishida; Kenji Wakai; Chisa Okada; Seiko Shimizu; Masayuki Sakiyama; Toshinori Chiba; Hiraku Ogata; Kazuki Niwa; Makoto Hosoyamada; Atsuyoshi Mori; Nobuyuki Hamajima; Hiroshi Suzuki; Yoshikatsu Kanai; Yutaka Sakurai; Tatsuo Hosoya; Toru Shimizu; Nariyoshi Shinomiya
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.